[Photodynamic therapy for neovascular age-related macular degeneration]

Department of Science and Technology - Brazilian Health Technology Assessment General Coordination
Record ID 32006001469
Portuguese
Authors' objectives:

The objective of this review is to examine the effects of photodynamic therapy in the treatment of neovascular age-related macular degeneration.

Authors' recommendations: Photodynamic therapy in people with choroidal neovascularization due to neovascular age-related macular degeneration is effective in preventing vision loss. The results and potential adverse effects of this treatment should be followed closely. Additional independent trials of Verteporfin are necessary in order to prove that the effects observed in this study are consistent and to determine important, but as yet unsolved, issues, especially regarding quality of life and cost.
Details
Project Status: Completed
URL for project: http://portal.saude.gov.br/portal/arquivos/pdf/photo_dinamic_therapy.pdf
Year Published: 2005
URL for published report: http://portal2.saude.gov.br/rebrats/visao/estudo/detEstudo.cfm?codigo=300&evento=6&v=true
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Brazil
MeSH Terms
  • Humans
  • Macular Degeneration
  • Photochemotherapy
  • Photosensitizing Agents
Contact
Organisation Name: Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
Contact Address: Ministerio da Saude, Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia, Esplanada dos Ministerios, Edificio sede; bl "G" - 8 andar - SL 834, CEP: 70058-900, Brasilia, DF Brazil, Tel: +55 61 3315 3197 Fax: +55 61 3315 3850
Contact Name: suzanne.jacob@saude.gov.br
Contact Email: suzanne.jacob@saude.gov.br
Copyright: Department of Science and Technology - Brazilian Health Technology Assessment General Coordination (DECIT-CGATS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.